() shares jumped higher on Friday as the firm said its 96 SARS-CoV-2 Kit for detecting coronavirus (COVID-19) infections is now CE-IVD marked and available for commercial sale across the European Union (EU). Now that CE-IVD marking has been achieved, the company can commence commercial sales in the UK and across the EU immediately. The company said it will begin distribution to potential customers for initial clinical evaluations and aims to record first commercial sales in June. The Genedrive 96 SARS-CoV-2 Kit is a new polymerase chain reaction (PCR) diagnostic test designed to detect active infection in coronavirus (COVID-19) patients.
() shares rose on Friday as the firm revealed that tariffs increased in its financial year ended March 31, 2020, following hikes in October 2018, and power generation ticked-up, though it remained cautious on the coronavirus (COVID-10) lockdown impact in India in the current year. In a trading and coronavirus (COVID-19) update, the developer and operator of power generation plants in India said its total generation (including deemed) was 2.72 billion units, up from the previous year’s 2.71 billion units figure, with its plant load factor (PLF) flat at 75%. The group said the average tariff in the period was Rs5.67, up 4.8% on the previous year’s Rs5.41 figure, which reflected a full years impact of tariff increases in October 2018 for captive users.
PLC () () said it is planning to spin out its StemPrintER and SPARE genomics-based personalised medicine businesses as a separate stock market quoted company. This will allow the newly independent group to secure independent funding to accelerate the accelerated development of the StemPrintER genomic test, the group said. It will also ensure the demerged entity can focus solely on the personalised medicines market. Tiziana said its shareholders would benefit from holding shares in both Tiziana, which has a rapidly developing drug portfolio while realising the “standalone value” of StemPrintER operation as it progresses through its own development milestones.
PLC () continues to trade in line with expectations, the group revealed ahead of its annual general meeting (AGM) on Friday. The intellectual property (IP) rights firm focused on the entertainment industry said the positive momentum referred to in its trading statement of May 6 has continued. Claire Blunt, the non-executive chairperson of One Media, is set to remind shareholders at the (virtual) meeting that “One Media is one of the few businesses which has been able to declare a dividend in challenging macro-economic times”. In a separate statement, One Media IP said that at the AGM all of the resolutions were duly passed.
() has confirmed a 13% rise in ‘system sales’ and more broadly a 16% increase in revenue during 2019, reflecting a business with some advantage when it…